![Matthew Greenhawt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 320 320 $ al 30/06/2026
Matthew Greenhawt is currently Chief Medical Officer at Aquestive Therapeutics, Inc. starting in 2026.
Formerly, Mr. Greenhawt was Chief Medical Officer at the Asthma & Allergy Foundation of America.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/03/2026 | 77.000 ( 0,06 % ) | 320 320 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 18/02/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Asthma & Allergy Foundation of America
 Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director Técnico/Científico/I+D | 01/01/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Asthma & Allergy Foundation of America
Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
